Regulation of Epithelial-to-Mesenchymal Transition by Alternative Translation Initiation Mechanisms and Its Implications for Cancer Metastasis

被引:16
|
作者
Bera, Amit [1 ]
Lewis, Stephen M. [1 ,2 ,3 ]
机构
[1] Atlantic Canc Res Inst, Moncton, NB E1C 8X3, Canada
[2] Univ Moncton, Dept Chem & Biochem, Moncton, NB E1A 3E9, Canada
[3] Beatrice Hunter Canc Res Inst, Halifax, NS B3H 4R2, Canada
关键词
epithelial-to-mesenchymal transition (EMT); IRES; m(6)A-mediated translation; ITAF; cancer; metastasis; IRES-MEDIATED TRANSLATION; RIBOSOME ENTRY SITES; MESSENGER-RNA; BREAST-CANCER; LAMININ B1; INTERNAL INITIATION; PROTEIN-SYNTHESIS; MIR-200; FAMILY; ACTING FACTORS; EXPRESSION;
D O I
10.3390/ijms21114075
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Translation initiation plays a critical role in the regulation of gene expression for development and disease conditions. During the processes of development and disease, cells select specific mRNAs to be translated by controlling the use of diverse translation initiation mechanisms. Cells often switch translation initiation from a cap-dependent to a cap-independent mechanism during epithelial-to-mesenchymal transition (EMT), a process that plays an important role in both development and disease. EMT is involved in tumor metastasis because it leads to cancer cell migration and invasion, and is also associated with chemoresistance. In this review we will provide an overview of both the internal ribosome entry site (IRES)-dependent and N-6-methyladenosine (m(6)A)-mediated translation initiation mechanisms and discuss how cap-independent translation enables cells from primary epithelial tumors to achieve a motile mesenchymal-like phenotype, which in turn drives tumor metastasis.
引用
收藏
页码:1 / 16
页数:16
相关论文
共 50 条
  • [41] Epithelial-to-Mesenchymal Transition in a Virally Induced Cancer
    Culig, Zoran
    JOURNAL OF UROLOGY, 2015, 193 (02): : 396 - 397
  • [42] Epithelial-to-mesenchymal transition in cancer: complexity and opportunities
    Zhang, Yun
    Weinberg, Robert A.
    FRONTIERS OF MEDICINE, 2018, 12 (04) : 361 - 373
  • [43] Metabolic reprogramming and epithelial-to-mesenchymal transition in cancer
    Sciacovelli, Marco
    Frezza, Christian
    FEBS JOURNAL, 2017, 284 (19) : 3132 - 3144
  • [44] Epithelial-to-mesenchymal transition in cancer: complexity and opportunities
    Yun Zhang
    Robert A. Weinberg
    Frontiers of Medicine, 2018, 12 : 361 - 373
  • [45] Epithelial-to-Mesenchymal Transition and MicroRNAs in Lung Cancer
    Legras, Antoine
    Pecuchet, Nicolas
    Imbeaud, Sandrine
    Pallier, Karine
    Didelot, Audrey
    Roussel, Helene
    Gibault, Laure
    Fabre, Elizabeth
    Le Pimpec-Barthes, Francoise
    Laurent-Puig, Pierre
    Blons, Helene
    CANCERS, 2017, 9 (08):
  • [46] New Insights into the Epithelial-to-Mesenchymal Transition in Cancer
    Qi, Xiaolong
    Zhang, Li
    Lu, Xiaojie
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2016, 37 (04) : 246 - 248
  • [47] Circulating Tumor Cells and Implications of the Epithelial-to-Mesenchymal Transition
    Lowes, Lori E.
    Allan, Alison L.
    ADVANCES IN CLINICAL CHEMISTRY, VOL 83, 2018, 83 : 121 - 181
  • [48] Roles and epigenetic regulation of epithelial–mesenchymal transition and its transcription factors in cancer initiation and progression
    Jeong-Yeon Lee
    Gu Kong
    Cellular and Molecular Life Sciences, 2016, 73 : 4643 - 4660
  • [49] Control of Invasion by Epithelial-to-Mesenchymal Transition Programs during Metastasis
    Pearson, Gray W.
    JOURNAL OF CLINICAL MEDICINE, 2019, 8 (05)
  • [50] Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance
    Kari R. Fischer
    Anna Durrans
    Sharrell Lee
    Jianting Sheng
    Fuhai Li
    Stephen T. C. Wong
    Hyejin Choi
    Tina El Rayes
    Seongho Ryu
    Juliane Troeger
    Robert F. Schwabe
    Linda T. Vahdat
    Nasser K. Altorki
    Vivek Mittal
    Dingcheng Gao
    Nature, 2015, 527 : 472 - 476